Clearstead Trust, LLC Alnylam Pharmaceuticals, Inc. Transaction History
Clearstead Trust, LLC
- $414 Million
- Q4 2024
A detailed history of Clearstead Trust, LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Clearstead Trust, LLC holds 3,981 shares of ALNY stock, worth $997,598. This represents 0.23% of its overall portfolio holdings.
Number of Shares
3,981
Previous 3,981
-0.0%
Holding current value
$997,598
Previous $1.1 Million
14.52%
% of portfolio
0.23%
Previous 0.29%
Shares
3 transactions
Others Institutions Holding ALNY
# of Institutions
667Shares Held
112MCall Options Held
839KPut Options Held
771K-
Capital World Investors Los Angeles, CA16.6MShares$4.16 Billion0.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$3.19 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.39 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.97MShares$1.75 Billion0.35% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.38MShares$1.1 Billion0.64% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $30.8B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...